Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$415M |
| 2 |
Tesla
TSLA
|
+$360M |
| 3 |
Capital One
COF
|
+$328M |
| 4 |
Johnson & Johnson
JNJ
|
+$168M |
| 5 |
EMA
Emera Incorporated
EMA
|
+$164M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$1.03B |
| 3 |
DFS
Discover Financial Services
DFS
|
+$296M |
| 4 |
Eli Lilly
LLY
|
+$215M |
| 5 |
Amazon
AMZN
|
+$205M |
Sector Composition
| 1 | Technology | 34.3% |
| 2 | Financials | 13.54% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 9.2% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Iovance Biotherapeutics
IOVA
$876M
| $400K | ﹤0.01% |
232,697
+208
| +0.1% | +$358 |
|
2502
Krispy Kreme
DNUT
$539M
| $399K | ﹤0.01% |
137,268
+41,929
| +44% | +$122K |
|
2503
Semrush
SEMR
$1.1B
| $398K | ﹤0.01% |
44,002
+5,709
| +15% | +$51.7K |
|
2504
MediaAlpha
MAX
$692M
| $398K | ﹤0.01% |
36,315
+8,229
| +29% | +$90.1K |
|
2505
Aspen Aerogels
ASPN
$560M
| $397K | ﹤0.01% |
67,130
+2,324
| +4% | +$13.8K |
|
2506
Tecnoglass
TGLS
$3.36B
| $396K | ﹤0.01% |
5,115
+987
| +24% | +$76.4K |
|
2507
Atlanta Braves Holdings Series A
BATRA
$2.84B
| $394K | ﹤0.01% |
8,007
+614
| +8% | +$30.2K |
|
2508
Lindblad Expeditions
LIND
$717M
| $394K | ﹤0.01% |
33,725
+685
| +2% | +$7.99K |
|
2509
GoodRx Holdings
GDRX
$1.47B
| $393K | ﹤0.01% |
78,821
+21,607
| +38% | +$108K |
|
|
DCBO
2510
Docebo
DCBO
$863M
| $392K | ﹤0.01% |
13,566
| – | – |
|
2511
Scorpio Tankers
STNG
$2.92B
| $391K | ﹤0.01% |
9,985
+1,005
| +11% | +$39.3K |
|
2512
The RealReal
REAL
$1.02B
| $389K | ﹤0.01% |
81,292
+10,052
| +14% | +$48.1K |
|
2513
Cross Country Healthcare
CCRN
$455M
| $389K | ﹤0.01% |
29,837
-7,394
| -20% | -$96.5K |
|
2514
Relay Therapeutics
RLAY
$700M
| $389K | ﹤0.01% |
112,316
-16,899
| -13% | -$58.5K |
|
2515
Willis Lease Finance
WLFC
$1.13B
| $385K | ﹤0.01% |
2,696
+79
| +3% | +$11.3K |
|
2516
Arbutus Biopharma
ABUS
$886M
| $385K | ﹤0.01% |
124,486
+6,089
| +5% | +$18.8K |
|
2517
VivoPower
VVPR
$50.6M
| $383K | ﹤0.01% |
+95,830
| New | +$383K |
|
2518
Arvinas
ARVN
$575M
| $381K | ﹤0.01% |
51,806
-1,581
| -3% | -$11.6K |
|
|
CRON
2519
Cronos Group
CRON
$969M
| $374K | ﹤0.01% |
195,368
+27,111
| +16% | +$51.9K |
|
2520
Standard BioTools
LAB
$489M
| $373K | ﹤0.01% |
310,435
+63,484
| +26% | +$76.2K |
|
2521
Covenant Logistics
CVLG
$575M
| $372K | ﹤0.01% |
15,442
+1,435
| +10% | +$34.6K |
|
2522
JELD-WEN Holding
JELD
$537M
| $372K | ﹤0.01% |
94,857
+18,615
| +24% | +$73K |
|
2523
Day One Biopharmaceuticals
DAWN
$744M
| $370K | ﹤0.01% |
56,864
-3,701
| -6% | -$24.1K |
|
2524
Hyster-Yale Materials Handling
HY
$637M
| $369K | ﹤0.01% |
9,284
+654
| +8% | +$26K |
|
2525
MindMed
MNMD
$734M
| $368K | ﹤0.01% |
56,703
-590
| -1% | -$3.83K |
|